my account
log out
|
|
my account
log out
|
Cabotegravir (GSK744, GSK1265744) |
| Create: 09/23/2019 |
| Expired Date: | never |
| Category: | Chemical |
| Message: | Cabotegravir (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor against a broad range of HIV subtypes, and inhibits the HIV-1 integrase catalyzed strand transfer reaction with IC50 of 3.0 nM. Phase 2.https://www.bocsci.com/cabotegravir-gsk744-gsk1265744-cas-1051375-10-0-item-463362.html |
 | |
| City: | New York[US]
 |
| Location: |
|
| Sep 23 2019 |  | Y-27632 2HCl | 260 |
| Sep 23 2019 | | BMS-911543 | 275 |
| Sep 23 2019 | | JQ-1 cas 1268524-70-4 | 263 |
| Sep 23 2019 | | Alectinib | 256 |
| Sep 23 2019 | | Tubastatin A | 268 |
| Sep 23 2019 | | FLLL32 | 265 |
| Sep 23 2019 | | Thiazovivin | 269 |
| Sep 23 2019 | | Alpelisib | 270 |
| Sep 23 2019 | | Ribociclib | 247 |
| Sep 23 2019 | | Midostaurin | 244 |
| Copyright © toextrade Inc. All rights reserved. Contact us |